Sun Yat-sen University Cancer Center
Clinical trials sponsored by Sun Yat-sen University Cancer Center, explained in plain language.
-
Could chemo after surgery keep esophageal cancer at bay?
Disease control Recruiting nowThis trial investigates whether giving chemotherapy (docetaxel and nedaplatin) after surgery can prevent esophageal cancer from returning. Patients with a certain stage of thoracic esophageal squamous cell carcinoma who had their tumor fully removed are randomly assigned to recei…
Phase: NA • Sponsor: Sun Yat-Sen University Cancer Center • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Could a common antibiotic boost chemo for tough breast cancer?
Disease control Recruiting nowThis phase 3 trial is testing whether adding the antibiotic moxifloxacin to standard chemotherapy (gemcitabine and carboplatin) helps people with metastatic triple-negative breast cancer live longer without their cancer growing. About 228 participants will receive either the anti…
Phase: PHASE3 • Sponsor: Sun Yat-Sen University Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New combo therapy aims to control brain tumors in lung cancer patients
Disease control Recruiting nowThis study tests whether adding the drug bevacizumab to a precise type of radiation therapy (fractionated stereotactic radiotherapy) can better control multiple brain tumors that have spread from lung adenocarcinoma. About 258 adults with 1 to 20 brain metastases will take part. …
Phase: PHASE3 • Sponsor: Sun Yat-Sen University Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC